These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 35372550)
1. Pre-conditioning Strategies for Mesenchymal Stromal/Stem Cells in Inflammatory Conditions of Livestock Species. Uberti B; Plaza A; Henríquez C Front Vet Sci; 2022; 9():806069. PubMed ID: 35372550 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in pre-conditioned mesenchymal stem/stromal cell (MSCs) therapy in organ failure; a comprehensive review of preclinical studies. Kahrizi MS; Mousavi E; Khosravi A; Rahnama S; Salehi A; Nasrabadi N; Ebrahimzadeh F; Jamali S Stem Cell Res Ther; 2023 Jun; 14(1):155. PubMed ID: 37287066 [TBL] [Abstract][Full Text] [Related]
4. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties. Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718 [TBL] [Abstract][Full Text] [Related]
5. Pre-conditioning of Equine Bone Marrow-Derived Mesenchymal Stromal Cells Increases Their Immunomodulatory Capacity. Caffi V; Espinosa G; Gajardo G; Morales N; Durán MC; Uberti B; Morán G; Plaza A; Henríquez C Front Vet Sci; 2020; 7():318. PubMed ID: 32656251 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation. Nold P; Hackstein H; Riedlinger T; Kasper C; Neumann A; Mernberger M; Fölsch C; Schmitt J; Fuchs-Winkelmann S; Barckhausen C; Killer M; Neubauer A; Brendel C Cytotherapy; 2015 Feb; 17(2):152-62. PubMed ID: 25453724 [TBL] [Abstract][Full Text] [Related]
7. Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy. Miceli V World J Stem Cells; 2024 Jan; 16(1):7-18. PubMed ID: 38292438 [TBL] [Abstract][Full Text] [Related]
8. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. Hu C; Wu Z; Li L J Cell Mol Med; 2020 Jan; 24(1):40-49. PubMed ID: 31691463 [TBL] [Abstract][Full Text] [Related]
10. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells. Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596 [TBL] [Abstract][Full Text] [Related]
11. Different priming strategies improve distinct therapeutic capabilities of mesenchymal stromal/stem cells: Potential implications for their clinical use. Miceli V; Zito G; Bulati M; Gallo A; Busà R; Iannolo G; Conaldi PG World J Stem Cells; 2023 May; 15(5):400-420. PubMed ID: 37342218 [TBL] [Abstract][Full Text] [Related]
12. Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review. Dave C; Mei SHJ; McRae A; Hum C; Sullivan KJ; Champagne J; Ramsay T; McIntyre L Elife; 2022 Jul; 11():. PubMed ID: 35838024 [TBL] [Abstract][Full Text] [Related]
13. Musculoskeletal Progenitor/Stromal Cell-Derived Mitochondria Modulate Cell Differentiation and Therapeutical Function. Jorgensen C; Khoury M Front Immunol; 2021; 12():606781. PubMed ID: 33763061 [TBL] [Abstract][Full Text] [Related]
14. Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis. Dave C; McRae A; Doxtator E; Mei SHJ; Sullivan K; Wolfe D; Champagne J; McIntyre L Syst Rev; 2020 Aug; 9(1):188. PubMed ID: 32814560 [TBL] [Abstract][Full Text] [Related]
15. Latest advances to enhance the therapeutic potential of mesenchymal stromal cells for the treatment of immune-mediated diseases. Ceruso A; Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM Drug Deliv Transl Res; 2021 Apr; 11(2):498-514. PubMed ID: 33634433 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury. Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256 [TBL] [Abstract][Full Text] [Related]
17. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors. Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG Front Immunol; 2020; 11():54. PubMed ID: 32117234 [TBL] [Abstract][Full Text] [Related]
19. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model. Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934 [TBL] [Abstract][Full Text] [Related]